# An Evaluation of a Novel Glucose Sensing Technology in Type 2 Diabetes

Study · id `cardio:ct-nct02082184` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02082184](<https://clinicaltrials.gov/study/NCT02082184>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02082184

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 302 participants.

## Technical summary

Registry record NCT02082184. Randomized; no masking; primary purpose other. Start 2014-03 (registry gives no type); primary completion 2015-06 (actual). Results posted on 2017-04-14.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 302 participants (enrolled count; ClinicalTrials.gov record NCT02082184, source copy `cardio:ctgov-nct02082184-2017-05-30`, retrieved 2026-10-26)
- Start date: 2014-03 (registry gives no type) (ClinicalTrials.gov record NCT02082184, source copy `cardio:ctgov-nct02082184-2017-05-30`, retrieved 2026-10-26)
- Primary completion: 2015-06 (actual) (ClinicalTrials.gov record NCT02082184, source copy `cardio:ctgov-nct02082184-2017-05-30`, retrieved 2026-10-26)
- Completion: 2015-12 (actual) (ClinicalTrials.gov record NCT02082184, source copy `cardio:ctgov-nct02082184-2017-05-30`, retrieved 2026-10-26)
- Results first posted: 2017-04-14 (ClinicalTrials.gov record NCT02082184, source copy `cardio:ctgov-nct02082184-2017-05-30`, retrieved 2026-10-26)
- Countries: France; Germany; United Kingdom (ClinicalTrials.gov record NCT02082184, source copy `cardio:ctgov-nct02082184-2017-05-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02082184-2017-05-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: An Evaluation of a Novel Glucose Sensing Technology in Type 2 Diabetes
- Acronym: REPLACE
- Condition: Type 2 Diabetes Mellitus
- Intervention (Device): Sensor Based Glucose Monitoring System
- Intervention (Device): Standard Blood Glucose Monitoring
- Lead sponsor: Abbott Diabetes Care
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Abbott Diabetes Care (`cardio:org-abbott-diabetes-care`)

## Provenance

Content hash: b3dccb8f214d2145d296cbc95caf58b92e7eb9b35e376c3227a2760cc7787a5c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
